Company profile
Azenta, Inc.
NASDAQ: AZTA · Healthcare · Medical - Instruments & Supplies
#200 of 1,418 Healthcare companies by revenue74th-percentile growth
EA Score
75B+FH 73DQ 78GM 69SS 89
v0.1 · 65/100 weight · provisional
↑ listing tenure, workforce scale · ↓ Piotroski F, growth stability
Methodology →Revenue TTM
$596.6M
Rev growth YoY (TTM)
+1.8%
Net income (FY)
-$55.8M
Employees
3,000
as of 2026-08-10
Market cap
$1.5B
as of 2026-08-10
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$593.8M$593.8M2025
Net income-$55.8M-$55.8M2025
Operating income-$26.8M-$26.8M2025
Total assets$2.1B$2.1B2025
Liabilities$332.6M$332.6M2025
Equity$1.7B$1.7B2025
Revenue trend
FY2025 – FY2025 · USD
FY25
FY25
FY25
FY24
FY25
FY25
FY25
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Service71%
Product29%
By geography
Europe48%
CHINA26%
UNITED KINGDOM16%
Asia Pacific10%
The read
What is Azenta, Inc.’s revenue?
Azenta, Inc. booked $593.8M in FY2025 revenue, growing 37% year over year — faster than most Healthcare companies we track, at a -9.4% net margin.
Peers · Healthcare
TransMedics Group, Inc.77B+UFP Technologies, Inc.80B+Veradigm Inc.——Catalyst Pharmaceuticals, Inc.83B+Hinge Health, Inc.47DBioventus Inc.66BNeighbors
Middlesex →Key facts
CEOJohn Marotta
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersBurlington, MA
ExchangeNASDAQ: AZTA
Employees3,000
IPO date1995-02-02
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.